Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
405
-
Total 13F shares, excl. options
-
88M
-
Shares change
-
-140K
-
Total reported value, excl. options
-
$10.5B
-
Value change
-
-$47.5M
-
Put/Call ratio
-
0.87
-
Number of buys
-
234
-
Number of sells
-
-164
-
Price
-
$119.80
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2018
484 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q4 2018.
DEXCOM INC - Common Stock (DXCM) has 405 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88M shares
of 392M outstanding shares and own 22.48% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (8.65M shares), JPMORGAN CHASE & CO (5.23M shares), MORGAN STANLEY (5.22M shares), BlackRock Inc. (5.09M shares), FMR LLC (5.07M shares), BAILLIE GIFFORD & CO (4.93M shares), BROWN ADVISORY INC (2.93M shares), WELLINGTON MANAGEMENT GROUP LLP (2.75M shares), STATE STREET CORP (1.68M shares), and HealthCor Management, L.P. (1.47M shares).
This table shows the top 405 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.